PBRM1 and cancer: Moreover, investigating the clinical impact of AS alterations of PBRM1 E27, specifically targeting each cancer type, may provide a comprehensive understanding of cancer type-specific roles of PBRM1, providing a new biomarker to predict the therapeutic efficiency of immune checkpoint blockade.